[1]
|
Handbook of Stem Cell Therapy
2022
DOI:10.1007/978-981-16-6016-0_34-1
|
|
|
[2]
|
Handbook of Stem Cell Therapy
2022
DOI:10.1007/978-981-19-2655-6_34
|
|
|
[3]
|
Handbook of Stem Cell Therapy
2022
DOI:10.1007/978-981-16-6016-0_34-1
|
|
|
[4]
|
Flavonols as potential antiviral drugs targeting SARS-CoV-2 proteases (3CLpro and PLpro), spike protein, RNA-dependent RNA polymerase (RdRp) and angiotensin-converting enzyme II receptor (ACE2)
European Journal of Pharmacology,
2021
DOI:10.1016/j.ejphar.2020.173759
|
|
|
[5]
|
Coronavirus Disease - COVID-19
Advances in Experimental Medicine and Biology,
2021
DOI:10.1007/978-3-030-63761-3_26
|
|
|
[6]
|
Coronavirus Disease - COVID-19
Advances in Experimental Medicine and Biology,
2021
DOI:10.1007/978-3-030-63761-3_26
|
|
|
[7]
|
Flavonols as potential antiviral drugs targeting SARS-CoV-2 proteases (3CLpro and PLpro), spike protein, RNA-dependent RNA polymerase (RdRp) and angiotensin-converting enzyme II receptor (ACE2)
European Journal of Pharmacology,
2021
DOI:10.1016/j.ejphar.2020.173759
|
|
|
[8]
|
COVID-19: Transmission, prevention, and potential therapeutic opportunities
Clinica Chimica Acta,
2020
DOI:10.1016/j.cca.2020.05.044
|
|
|